Early detection of heart arrhythmias.

The Know Your Rhythm™ program helps your members or patients determine their risk of AFib or other clinically actionable arrhythmias by monitoring for irregular heartbeats. Provide them with the answers they need, in-clinic or from the comfort of home.

Why monitor your heart?

Irregular heart rhythms are alarmingly common. In the U.S, an individual's lifetime risk of developing AFib is roughly 1 in 4.1 And yet, many who experience this don't even feel symptoms and aren't aware that they have it.2 Arrhythmias are a leading cause of stroke and increase the risk of other serious outcomes.3,5

The good news is that long-term, continuous heart monitoring is helping in the shift to more preventative and proactive treatment and care.2

irhythm-patch-kyr

Why monitor your heart?

Irregular heart rhythms are alarmingly common. In the U.S, an individual's lifetime risk of developing AFib is roughly 1 in 4.1 And yet, many who experience this don't even feel symptoms and aren't aware that they have it.2 Arrhythmias are a leading cause of stroke and increase the risk of other serious outcomes.3,5

The good news is that long-term, continuous heart monitoring is helping in the shift to more preventative and proactive treatment and care.2

⅓
Approx 1/3 of all AFib is asymptomatic at time of diagnosis4
5x
The risk of stroke is 5x greater with AFib3
3x
There is a 3x risk of developing heart failure if AF is a comorbidity5
25%
Percent of ischemic strokes caused by AFib in older adults6

heart icon
Easy-to-wear
cardiac monitoring.

Know Your Rhythm is powered by the industry-leading Zio XT, a small, discreet, comfortable heart monitor that allows you to continue normal activities including moderate exercise and showering. Zio XT records every single heartbeat, day and night over a 14-day period, so you and your doctor can get an accurate diagnosis and treat your irregular heart rhythm quickly.
irhythm-zio-patch

How does it work?

Your members simply enroll online or in-clinic according to age and comorbidity at-risk criteria. A Zio XT patch is then mailed to their home or applied in-clinic.
They wear the patch for 14 days, and then mail it back to iRhythm using the prepaid shipping box.
Your members' heartbeat data is analyzed to discover their rhythm, so they can get back to what matters most.

The details.

Payers
Providers
Payers
Providers
Monitoring saves lives and health care dollars.
Fewer ED visits, reduced hospital admissions, and reduced adverse cardiac outcomes (stroke, MI, systemic embolism and death).7,10
Address member satisfaction, growth, and retention.
4 out of 5 Medicare Advantage survey respondents indicated they would be more satisfied and likely to stay with their current plan if an early AFib detection program were offered to them at no cost.8
Positive financial impact
The Know Your Rhythm program has the potential to deliver $4.73PMPM in cost savings over three years.9*
LEARN MORE ABOUT OFFERING
KNOW YOUR RHYTHM
Proactive monitoring is the future of cardiac care.
Implement a new care pathway for early detection of actionable arrhythmias.
Improve healthcare resource utilization (HCRU) and outcomes. 7,10
Improved population health and a positive net financial impact for your capitated lives.
LEARN MORE ABOUT OFFERING
KNOW YOUR RHYTHM

heart icon
Payers + Healthcare Providers
Want to learn more?

Let’s talk and see if the Know Your Rhythm program is right for your organization.
  1. Staerk, et al., Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018.
  2. mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for At-Risk Patient Populations, iRhythm Technologies, 2021.
  3. Wolf, et al., Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991.
  4. Sgreccia, et al., Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. Journal of Clinical Medicine MDPI, 2021.
  5. Kotecha, et al., Atrial fibrillation in heart failure: what should we do? Eur Heart J., 2015.
  6. Alkhouli, et al., Burden of Atrial Fibrillation–Associated Ischemic Stroke in the United States. JACC: Clinical Electrophysiology, 2018.
  7. Steinhubl, et al. Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening—mHealth Screening to Prevent Strokes (mSToPS). PLOS ONE, 2021.
  8. Market survey of 200 respondents currently enrolled in a Medicare Advantage plan. Data on file. iRhythm Technologies, 2022.
  9. Directional and potential outcome based upon modeling using iRhythm’s mSToPS
    Calculator. iRhythm Technologies, 2023.
    *Assumes 10,000 members, 2,500 eligible with 25% participation.
  10. Waalen, et al. Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation. Heart Rhythm O2, 2020.